Results for Oncology

1 - 10 of 372

Dr. Evageliou is an attending physician in the Division of Oncology. His research interest is in renal tumors, neuroblastoma, and solid tumors. He is a member of the Renal Tumors Committee of the Children's Oncology Group, where he helps create clinical trials for Wilms tumors.

E-mail:

evageliou [at] chop.edu

Leslie S. Kersun, MD, MSCE, MSEd

Dr. Kersun has a strong interest in trainee education and collaborates with colleagues at Children's Hospital of Philadelphia and other institutions to develop innovative methods of teaching various topics in oncology. She also engages in collaborative research related to the communication of difficult news to patients.

E-mail:

segall [at] chop.edu

Jason L. Freedman, MD, MSCE

Dr. Freedman has a particular interest in epidemiologic and translational research within pediatric supportive oncology. He aims to advance the understanding and treatment of symptoms, infections, and organ toxicities in pediatric cancer and hematopoietic stem cell transplant patients.

E-mail:

freedmanj [at] chop.edu

Amish C. Shah, MD, PhD

Dr. Shah's clinical research interests are focused in the areas of neurofibromatosis type 1 and retinoblastoma. These studies range from translational studies to clinical trials of novel therapeutics to international consortiums studying long-term effects of therapy.

E-mail:

shahac [at] chop.edu

Kelly D. Getz, PhD, MPH

Dr. Getz develops and applies advanced methods to enable epidemiologic research that aims to optimize the treatment and supportive care of children with cancer by balancing the therapeutic benefits and toxicity risks with an emphasis in cardio-oncology.

E-mail:

getzk [at] chop.edu

Susan R. Rheingold, MD

Dr. Rheingold's research interests center on acute lymphocytic leukemia, and she serves on the Children's Oncology Group's Relapsed ALL, Infant ALL, and Complementary Therapies committees. In addition, she is investigates complementary and alternative therapies, supportive care for oncology patients undergoing chemotherapy, medical education, and rare childhood tumors.

E-mail:

rheingold [at] chop.edu

Michael D. Hogarty, MD

Dr. Hogarty is a pediatric oncologist with 20 years' experience as a physician-scientist with a careerlong focus on neuroblastoma translational biology.

E-mail:

hogartym [at] chop.edu

Stephen P. Hunger, MD

Dr. Hunger's focuses his research on molecular and genomic approaches to identify and clinically evaluate targeted cancer treatments for children with relapsed or high-risk acute lymphoblastic leukemia (ALL) such as Philadelphia chromosome-like (Ph-Like) ALL. The long-term goal of Dr. Hunger’s research is to develop better therapies, improve cure rates, and minimize treatment toxicities for children with ALL.

E-mail:

hungers [at] chop.edu

Caitlin Elgarten, MD, MSCE

Dr. Caitlin Elgarten is an attending physician with the Cancer Center at Children's Hospital of Philadelphia and an assistant professor of Pediatrics in the Perelman School of Medicine at the University of Pennsylvania. Her research focuses on pediatric hematology-oncology.

E-mail:

elgartenc [at] chop.edu

Regina Myers, MD

Dr. Myers aims to improve outcomes for children and young adults receiving cellular immunotherapies for high-risk hematologic toxicities. Her current research is focused on studying toxicities of CAR T-cell therapies through a combination of clinical epidemiologic and translational research methods.

E-mail:

myersrm [at] chop.edu